The 2023 South China Cardiac Intervention Forum (SCIF 2023) and the South China Intraluminal Imaging and Functionality Summit Forum, as well as the Guangzhou Cardiac
On October 7, 2023, the change of application for myPKFiT® (a pharmacokinetic-dosing software for Recombinant Human Coagulation Factor Ⅷ for Injection) submitted by Takeda, a
CurvRITE Growth Guidance System developed by SpineGuide, a domestic medical device enterprise focusing on the research and development of spine products, obtained the FDA designation
The 2023 South China Cardiac Intervention Forum (SCIF 2023) and the South China Intraluminal Imaging and Functionality Summit Forum, as well as the Guangzhou Cardiac
On October 7, 2023, the change of application for myPKFiT® (a pharmacokinetic-dosing software for Recombinant Human Coagulation Factor Ⅷ for Injection) submitted by Takeda, a
CurvRITE Growth Guidance System developed by SpineGuide, a domestic medical device enterprise focusing on the research and development of spine products, obtained the FDA designation
To improve the clinical service level of CROs in Shanghai and promote high-quality development of Shanghai biopharma industry, Shanghai Center for Biomedicine Development held the
